Evaluating diagnosis and outcomes of placenta accreta
Diagnosis and Outcomes of Placental Accretism
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06833606
This study is trying to see how different treatment options for placenta accreta affect mothers and their outcomes during and after pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 44 Years |
| Sex | Female |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 7 sites (Bologna, Bologna and 6 other locations) |
| Trial ID | NCT06833606 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the diagnostic criteria for placenta accreta and evaluate maternal outcomes based on different management strategies. It will involve both retrospective and prospective data collection from multiple centers across the nation. The study will analyze instrumental findings and clinical trends during pregnancy and postpartum to compare conservative management versus radical management approaches. The goal is to standardize the management of suspected placental accretism by understanding the implications of various treatment options.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women aged 18 to 44 with suspected placental accretism.
Not a fit: Patients outside the age range of 18 to 44 or those without suspected placental accretism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for placenta accreta, enhancing maternal and fetal outcomes.
How similar studies have performed: While there may be studies on placenta accreta, this specific approach to standardizing management based on diagnostic criteria and outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 years and 44 years * Pregnant women with suspected placental accretism * Acquisition of informed consent form Exclusion Criteria: None
Where this trial is running
Bologna, Bologna and 6 other locations
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (RECRUITING)
- Ospedale "M. Bufalini" — Cesena, Forlì-Cesena, Italy (RECRUITING)
- Ospedale "Morgagni-Pierantoni" — Forlì, Forlì-Cesena, Italy (RECRUITING)
- AOU Policlinico di Modena — Modena, Modena, Italy (RECRUITING)
- Azienda Ospedaliero - Universitaria di Parma — Parma, Parma, Italy (RECRUITING)
- Arcispedale Santa Maria Nuova — Reggio Emilia, Reggio Emilia, Italy (RECRUITING)
- Ospedale "Infermi" di Rimini — Rimini, Rimini, Italy (RECRUITING)
Study contacts
- Principal investigator: Gianluigi Pilu, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Gianluigi Pilu, MD
- Email: gianluigi.pilu@aosp.bo.it
- Phone: 0512143493
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Placenta Accreta, diagnosis